Human immunodeficiency virus type 1 antibody status and changes in risk behavior among drug users.
The associations of human immunodeficiency virus type 1 (HIV-1) antibody status and recent testing with risk behavior change were examined in a cohort of drug users enrolled in a randomized trial of acquired immunodeficiency syndrome (AIDS) education programs at a short-term inpatient detoxification facility. Four hundred ninety-seven subjects completed baseline interviews, and 402 (81%) of them had analyzable follow-up information. Changes in eight ordinal self-reported drug and sexual behaviors were assessed using the cumulative logit model for repeated ordinal response data. There was only limited evidence for differential behavior change by either perceived serostatus or recent testing, which was mainly confined to sharing of injection equipment among those who continued to inject, and condom use.
McCusker
J
J
School of Public Health, University of Massachusetts, Amherst.
Bigelow
C
C
Stoddard
A M
AM
Zorn
M
M
D000293:Adolescent; D000328:Adult; D017280:Condoms / Q000706:statistics & numerical data; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000523:psychology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D016485:Needle Sharing / Q000706:statistics & numerical data*; D012309:Risk-Taking; D012725:Sexual Behavior / Q000706:statistics & numerical data*; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000523:psychology*